A Fair Value — Agilent Technologies Inc

Life Sciences Tools · Institutional-depth multi-model valuation on Equity Rank

Current Price
$137.89
Consensus Fair Value
$131.54
Margin of Safety
-4.6%

When does A report earnings?

Agilent Technologies Inc (A) is next scheduled to report earnings on Aug 26, 2026. The consensus analyst EPS estimate for the upcoming quarter is $1.48.

Heading into this report, the model's fair value estimate sits 4.6% below the current price (model fair value differential below current price). Descriptive context only — not a forecast of the earnings result.

Earnings dates and estimates are sourced from third-party data and may change or lag. Informational only.

How A's valuation models agree

Equity Rank computed model fair value for A from 10 independent valuation methods with sufficient data. 4 place fair value above the current price of $137.89, and 6 place it below. The model-blended estimate lands at $131.54 — a model fair value differential of 4.6% below the current price under these model assumptions. The larger group places fair value below the current price.

Models: FV above price
4
Models: FV below price
6
Models compared
10

Each method (DCF, Graham Number, EPV, Three-Stage DCF, DDM, Residual Income, Justified Price-to-Book, and more) is weighted by historical sector accuracy. Model-derived and informational only — not investment advice.

A fundamental profile

Equity Rank's fundamental strength composite scores A at 66.4/100 (B, Solid), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +4.1% per year and gross margin has moved -1.9 pp. Its SAVE composite score has moved -0.4 over the past 30 days.

A composite quality metric for research context — not a rating, recommendation, or directional signal.

About A

Agilent Technologies Inc (A) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.

Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.

Related Life Sciences Tools Research

JNJ · UNH · PFE · ABBV · MRK

All Healthcare stocks with model fair values · Undervalued Healthcare stocks

Research Tools

Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator

Data study: 19 valuation models across 3,091 US stocks · Compare any two stocks